Cargando…

Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation

Mesenchymal stem cells (MSCs) have been shown to improve the outcome of acute renal injury models; but whether MSCs can delay renal failure in chronic kidney disease (CKD) remains unclear. In the present study, the were cultured in media containing various concentrations of basic fibroblast growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jei-Wen, Tsai, Hsin-Lin, Chen, Chang-Wei, Yang, Hui-Wen, Yang, An-Hang, Yang, Ling-Yu, Wang, Paulus S, Ng, Yee-Yung, Lin, Teng-Lung, Lee, Oscar K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393722/
https://www.ncbi.nlm.nih.gov/pubmed/22862802
http://dx.doi.org/10.1111/j.1582-4934.2012.01610.x
_version_ 1782366204236660736
author Chang, Jei-Wen
Tsai, Hsin-Lin
Chen, Chang-Wei
Yang, Hui-Wen
Yang, An-Hang
Yang, Ling-Yu
Wang, Paulus S
Ng, Yee-Yung
Lin, Teng-Lung
Lee, Oscar K
author_facet Chang, Jei-Wen
Tsai, Hsin-Lin
Chen, Chang-Wei
Yang, Hui-Wen
Yang, An-Hang
Yang, Ling-Yu
Wang, Paulus S
Ng, Yee-Yung
Lin, Teng-Lung
Lee, Oscar K
author_sort Chang, Jei-Wen
collection PubMed
description Mesenchymal stem cells (MSCs) have been shown to improve the outcome of acute renal injury models; but whether MSCs can delay renal failure in chronic kidney disease (CKD) remains unclear. In the present study, the were cultured in media containing various concentrations of basic fibroblast growth factor, epidermal growth factor and ascorbic acid 2-phosphate to investigate whether hepatocyte growth factor (HGF) secretion could be increased by the stimulation of these growth factors. Then, TGF-β1-treated renal interstitial fibroblast (NRK-49F), renal proximal tubular cells (NRK-52E) and podocytes were co-cultured with conditioned MSCs in the absence or presence of ascorbic acid 2-phosphate to quantify the protective effects of conditioned MSCs on renal cells. Moreover, male Sprague-Dawley rats were treated with 1 × 10(6) conditioned MSCs immediately after 5/6 nephrectomy and every other week through the tail vein for 14 weeks. It was found that basic fibroblast growth factor, epidermal growth factor and ascorbic acid 2-phosphate promoted HGF secretion in MSCs. Besides, conditioned MSCs were found to be protective against TGF-β1 induced epithelial-to-mesenchymal transition of NRK-52E and activation of NRK-49F cells. Furthermore, conditioned MSCs protected podocytes from TGF-β1-induced loss of synaptopodin, fibronectin induction, cell death and apoptosis. Rats transplanted with conditioned human MSCs had a significantly increase in creatinine clearance rate, decrease in glomerulosclerosis, interstitial fibrosis and increase in CD4(+)CD25(+)Foxp3(+) regulatory T cells counts in splenocytes. Together, our studies indicated that conditioned MSCs preserve renal function by their anti-fibrotic and anti-inflammatory effects. Transplantation of conditioned MSCs may be useful in treating CKD.
format Online
Article
Text
id pubmed-4393722
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43937222015-04-13 Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation Chang, Jei-Wen Tsai, Hsin-Lin Chen, Chang-Wei Yang, Hui-Wen Yang, An-Hang Yang, Ling-Yu Wang, Paulus S Ng, Yee-Yung Lin, Teng-Lung Lee, Oscar K J Cell Mol Med Original Articles Mesenchymal stem cells (MSCs) have been shown to improve the outcome of acute renal injury models; but whether MSCs can delay renal failure in chronic kidney disease (CKD) remains unclear. In the present study, the were cultured in media containing various concentrations of basic fibroblast growth factor, epidermal growth factor and ascorbic acid 2-phosphate to investigate whether hepatocyte growth factor (HGF) secretion could be increased by the stimulation of these growth factors. Then, TGF-β1-treated renal interstitial fibroblast (NRK-49F), renal proximal tubular cells (NRK-52E) and podocytes were co-cultured with conditioned MSCs in the absence or presence of ascorbic acid 2-phosphate to quantify the protective effects of conditioned MSCs on renal cells. Moreover, male Sprague-Dawley rats were treated with 1 × 10(6) conditioned MSCs immediately after 5/6 nephrectomy and every other week through the tail vein for 14 weeks. It was found that basic fibroblast growth factor, epidermal growth factor and ascorbic acid 2-phosphate promoted HGF secretion in MSCs. Besides, conditioned MSCs were found to be protective against TGF-β1 induced epithelial-to-mesenchymal transition of NRK-52E and activation of NRK-49F cells. Furthermore, conditioned MSCs protected podocytes from TGF-β1-induced loss of synaptopodin, fibronectin induction, cell death and apoptosis. Rats transplanted with conditioned human MSCs had a significantly increase in creatinine clearance rate, decrease in glomerulosclerosis, interstitial fibrosis and increase in CD4(+)CD25(+)Foxp3(+) regulatory T cells counts in splenocytes. Together, our studies indicated that conditioned MSCs preserve renal function by their anti-fibrotic and anti-inflammatory effects. Transplantation of conditioned MSCs may be useful in treating CKD. BlackWell Publishing Ltd 2012-12 2012-12-13 /pmc/articles/PMC4393722/ /pubmed/22862802 http://dx.doi.org/10.1111/j.1582-4934.2012.01610.x Text en © 2012 The Authors Journal of Cellular and Molecular Medicine © 2012 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
spellingShingle Original Articles
Chang, Jei-Wen
Tsai, Hsin-Lin
Chen, Chang-Wei
Yang, Hui-Wen
Yang, An-Hang
Yang, Ling-Yu
Wang, Paulus S
Ng, Yee-Yung
Lin, Teng-Lung
Lee, Oscar K
Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title_full Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title_fullStr Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title_full_unstemmed Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title_short Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
title_sort conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393722/
https://www.ncbi.nlm.nih.gov/pubmed/22862802
http://dx.doi.org/10.1111/j.1582-4934.2012.01610.x
work_keys_str_mv AT changjeiwen conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT tsaihsinlin conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT chenchangwei conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT yanghuiwen conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT yanganhang conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT yanglingyu conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT wangpauluss conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT ngyeeyung conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT lintenglung conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation
AT leeoscark conditionedmesenchymalstemcellsattenuateprogressionofchronickidneydiseasethroughinhibitionofepithelialtomesenchymaltransitionandimmunemodulation